medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2014, Number 6

<< Back Next >>

Salud Mental 2014; 37 (6)

Calidad de vida y discapacidad en el trastorno de ansiedad generalizada

Marjan LPMP, Mendieta CD, Muñoz SMA, Díaz AA, Cortés SJF

Language: Spanish
References: 30
Page: 509-516
PDF size: 282.46 Kb.


ABSTRACT

Objective To determine which clinical factors predict disability and poor quality of life in patients with generalized anxiety disorder.
Methodology This was a descriptive cross-sectional study. Data were analyzed using frequencies, percentages, mean. A linear regression analysis was used to determine how demographic factors predict clinical disability and poor quality of life.
Results. We found that the presence of a family history of anxiety disorders, as well as higher scores on the Hamilton Depression Scale, predict a lower quality of life; unlike an older age which predicts a higher quality of life in these patients. Higher levels of disability were associated with males, a younger age, comorbid Axis II disorders, the presence of a family history of anxiety disorders, and higher scores on the Hamilton Depression Scale.
Conclusions. Depressive symptoms and a family history of anxiety are associated with a poor quality of life. Knowing which factors predict the quality of life and disability in patients may guide us towards a more comprehensive diagnosis and treatment approach. This means will not just treat symptoms, but will seek patients’ functional recovery, which leads in turn to a better quality of life.


REFERENCES

  1. Comer JS, Blanco C, Hasin DS, Liu SM et al. Health related quality of life across the anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2011;72:43-50.

  2. Norton J, Ancelin M, Stewart R, Berr C et al. Anxiety symptoms and disorder predict activity limitations in the ederly. J Affective Disorders 2012;141:276-285.

  3. Medina-Mora ME, Borges G, Lara C, Benjet C et al. Prevalence of mental disorders and use of services: results from the Mexican National Survey of Psychiatric Epidemiology. Salud Mental 2003;26:1-16.

  4. Virgen R, Lara AC, Morales G, Villaseñor S. Los trastornos de ansiedad. Rev Dig Univ 2005;6:2-11.

  5. Tanja M, Zetsche U, Margraf J. Epidemiology of anxiety disorders. Psychiatry 2007;6:136-142.

  6. Jurado S, Quintana C, Vargas M, Lizarraga P et al. Ansiedad generalizada: componentes de preocupación en mexicanos. Rev Científica Psicología 2008;4:123-134.

  7. Allgulander C. Generalized anxiety disorder: a review of recent findings. J Exp Clin Med 2012;4:88-91.

  8. Blazer DG, Hughes D, George LK. Generalize anxiety disorder. New York: The Free Press; 1991; pp.180-203.

  9. Sadock B, Sadock V. Kaplan y Sadock. Sinopsis de psiquiatría. New York: Octava edición; Lippincott Williams and Wilkins; 2001; pp.705-710.

  10. Medina-Mora ME, Borges G, Lara C, Bejet Cet al. Prevalence, service use and demographic correlates of 12 month DSM-IV psychiatric disorders in México: Results from the Mexican National Comorbidity Survey. Psychological Medicine 2005;35:1-11.

  11. Ruiz MA, Zamorano E, Garcia-Campayo J, Pardo A et al. Validity of GAD -7 Scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. J Affective Disorders 2011;128:277-286.

  12. País-Ribeiro JL. Quality of life is a primary end-point in clinical settings. Clinical Nutrition 2004;23:121-130.

  13. Lara-Muñoz MC, Ponce de León S, De la Fuente JR. Conceptualización y medición de la calidad de vida de pacientes con cáncer. Rev Invest Clin 1995;47:315-327.

  14. Potter J, Cantarero R, Wood H. The multidimensional nature of predicting quality of life. Procedia-Social Behavioral Sciences 2012;50:781-790.

  15. Ware JE, Sherbourne CD. The MOS 36-item short form health survey (SF-36). Conceptual framework and item selection. Med Care 1992;30(6):473-483.

  16. Cheng HG, Hung YQ, Liu Z, Zhag M et al. Disability associated with mental disorders in metropolitan China: An application of the quantantile regression approach. Psychiatry Reserch 2012;199:212-219.

  17. Sheehan DV, Lecrubrier Y, Harnett-Sheehan K, Janavs J et al, Reliability and validity of the MINI International Neuropsychiatric Interview (MINI): according to the SCID-P. European Psychiatry 1997;12:232-241.

  18. Bobes J, Badia X, Luque A, García M et al. Validación de las versiones en español de los cuestionarios Liebowitz Social Anxiety Scale, Social Anxiety and Distress Scale, Sheehan Disability Inventory para la evaluación de la fobia social. Med Clin Barc 1999;112:530-538.

  19. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacology Bulletin 1993;29:321-326.

  20. Nicolini H, Villareal G, Ortega-Soto H, De la Fuente JR. Alteraciones de la memoria de pacientes con crisis de angustia y efecto del tratamiento farmacológico con alprazolam e imipramina. Salud Mental 1988;11:11-14.

  21. Lobo A, Chamorro L, Luque A, Dal-Re et al. Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y la ansiedad. Med Clin Barc 2002;118:493-499.

  22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:36-62.

  23. Ramos-Brieva JA, Cordero-Villafafila A. Validación de la versión castellana de la escala de Hamilton para la depresión. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1986;14:324-334.

  24. Rubio G, López-Ibor JJ. Generalized anxiety disorder: a 40-year follow up study. Acta Psychiatr Scand 2007:115:372–379.

  25. González-Pier E, Gutiérrez-Delgado C, Stevens G, Barraza-Lloréns M et al. Priority setting for health interventions in Mexico´s System of Social Protection in Health. Lancet 2006;368:1608-1618.

  26. Kessler RC, Chiu WT, Colpe L, Demler O et al. The prevalence and correlates of serious mental illness (SMI) in the National Comorbidity Survey Replication (NCS-R). Mental Health, United States. Oxford: Oxford University Press; 2004.

  27. Nutt D, Argyropoulos S, Hood S, Potokar J. Generalized anxiety disorder: A comorbid disease. European Neuropsychopharmacology 2006;16:109-118.

  28. Medina-Mora ME, Borges G, Fleiz C, Lara C et al. Prevalencia de sucesos violentos y trastorno por estrés postraumático en la población mexicana. Salud Pública México 2005;47:8-22.

  29. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorder. Am J Psychiatry 2000;157:669-682.

  30. Scott KM, Collings SCD. Gender and the association between mental disorders and disability J Affective Disorders 2010;125:207–212.




2020     |     www.medigraphic.com